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Formation and Abundance of 5-Hydroxymethylcytosine in
RNA
Sabrina M. Huber,[a] Pieter van Delft,[a] Lee Mendil,[b] Martin Bachman,[b] Katherine Smollett,[c]
Finn Werner,[c] Eric A. Miska,[d] and Shankar Balasubramanian*[a, b]
RNA methylation is emerging as a regulatory RNA modification
that could have important roles in the control and coordina-
tion of gene transcription and protein translation. Herein, we
describe an in vivo isotope-tracing methodology to demon-
strate that the ribonucleoside 5-methylcytidine (m5C) is subject
to oxidative processing in mammals, forming 5-hydroxymethyl-
cytidine (hm5C) and 5-formylcytidine (f5C). Furthermore, we
have identified hm5C in total RNA from all three domains of
life and in polyA-enriched RNA fractions from mammalian cells.
This suggests m5C oxidation is a conserved process that could
have critical regulatory functions inside cells.
Half a century of research has identified more than 140 distinct
post-transcriptional modifications of ribonucleic acids.[1] The
majority of these chemical modifications are found in the
highly abundant transfer and ribosomal RNAs (tRNA, rRNA,
95% of total RNA) where they contribute to RNA folding, pro-
vide structural stability and diversify molecular recognition, for
example, through “wobble base pairing”.[2] Recently RNA modi-
fications have also been identified in the less abundant mes-
senger and long noncoding RNAs (mRNA, lncRNA).[3,4] Given
the short half-life of many RNA species (t1/2<10 h), RNA modifi-
cations previously have been viewed largely as static and
stable marks. Recent studies, however, have shown that they
can be dynamic and might have critical regulatory and/or sig-
nalling roles inside cells, similar to the reversible epigenetic
marks on DNA and histones.[5] For instance, N6-methyladeno-
sine (m6A), the most abundant internal modification in eukary-
otic mRNA, undergoes oxidative processing to N6-hydroxyme-
thyladenosine and N6-formyladenosine by the fat mass and
obesity-associated protein (FTO) and ALKBH5, respectively.[6, 7]
Although the function of this dynamic adenosine methylation
is not yet fully understood, it is proposed to be involved in the
regulation of gene expression, mRNA stability and protein
translation.[8,9] 5-Methylcytidine (m5C) is another known methy-
lated ribonucleoside that is widespread across both coding
and noncoding RNAs from all domains of life.[2] Although 5-
methyl-2’-deoxycytidine (m5dC) is known to be an inheritable
epigenetic mark in DNA; the precise cellular and molecular
functions of m5C-modified nucleobases in RNA are not clearly
understood. Recent studies have shown that m5C sites in
lncRNAs can affect binding to chromatin-modifying complexes
in vitro;[4] this implies that RNA C5-methylation can affect the
epigenetic status of a cell. Furthermore, m5C in vault RNA has
been demonstrated to act as a molecular switch to produce
specific small vault RNAs, which can enter the micro RNA path-
way and influence the translation of distinct sets of mRNAs.[10]
These findings provide the first evidence that m5C in RNA
could be critical for the control and regulation of gene tran-
scription and protein translation, and prompted us to investi-
gate whether m5C in RNA is subject to dynamic control inside
organisms in a fashion similar to m6A.
Subsequent to the recent discovery of 5-hydroxymethyl-2’-
deoxycytosine (hm5dC) in mammalian DNA,[11] the dynamics
and oxidative metabolism of DNA C5-methylation have been
the subject of intense investigation. The ten-eleven transloca-
tion (TET) family of enzymes can mediate the removal of m5dC
through an oxidative pathway involving the distinct intermedi-
ates hm5dC, 5-formyl-2’-deoxycytosine and 5-carboxy-2’-deoxy-
cytosine.[12] Furthermore, studies on the lifetime of hm5dC have
demonstrated that it can be a stable DNA modification, thus
suggesting that hm5dC might have its own unique biological
function in addition to being an intermediate in m5dC remov-
al.[13]
In RNA, hm5C was originally identified in rRNA isolated from
wheat seedlings.[14] During the preparation of this manuscript,
Fu et al. reported the presence of hm5C for the first time in
mammalian total RNA and demonstrated that it can be formed
in vitro by TET-mediated oxidation of m5C.[15]
Herein, we present direct chemical evidence for the in vivo
oxidative processing pathway of m5C in RNA. Using an iso-
tope-tracing strategy in a mouse model followed by liquid
chromatography tandem-mass spectrometry (LC-MS/MS) analy-
sis, we were able to follow m5C metabolism in RNA. Further-
more, we quantified hm5C in total RNA samples from all do-
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mains of life and polyA-enriched mammalian RNA to better un-
derstand the scope and biological function of this noncanoni-
cal base in RNA.
To explore the in vivo metabolic pathway of 5-methylcyto-
sine in RNA and determine whether hm5C is indeed the result
of m5C oxidation, we carried out an isotope-tracing experiment
by using a mouse model. RNA methyltransferases (RMTases)
use S-adenosylmethionine (SAM) as the methyl-group donor in
all nucleoside methylation events.[2] As SAM is synthesized
from l-methionine,[16] feeding mice on a diet supplemented
with 13C and D stable-isotope-labelled methionine leads to the
incorporation of these isotopes into the C5-methyl group of
m5C. Consequently, isolation of the murine RNA and the LC-
MS/MS analysis thereof, enables the detection of isotope-la-
belled m5C and any derivatives that are formed directly from it.
Mice were fed on a custom diet depleted of l-methionine
and supplemented with l-[methyl-13CD3]methionine for 117
days.[13] The mice were then sacrificed, and RNA was extracted
from their brain tissue, which was then digested by a mixture
of nucleases and phosphatases to form the nucleoside mono-
mers. Incorporation of the 13CD3 label was then assessed by
LC-MS/MS analysis of the RNA nucleosides, with the mass fil-
ters of the triple quadrupole preset for m5C and m5C+4 Da.
This revealed that the 13CD3 label had been incorporated in
51% of total m5C (Scheme 1). Next, we detected the masses of
hm5C and f5C and their expected isotopologues hm5C+3 Da
and f5C+2 Da, respectively. As depicted in Scheme 1, we ob-
served 13C and D isotope incorporation into hm5C and f5C with
similar efficiencies as for m5C (hm5C: 41%, f5C: 39%). These
findings confirm that m5C in RNA can be oxidatively metabo-
lized first to hm5C and subsequently to f5C. In the recently
published study on TET-mediated oxidation of m5C to hm5C in
synthetic RNA oligonucleotides, no significant sequential in
vitro oxidation of hm5C to f5C was observed.[15]
The conservation of m5C in RNA across Archaea, bacteria
and eukaryotes[2] and the apparent metabolic relationship be-
tween m5C and hm5C in vivo suggest that RNA C5-hydroxyme-
thylation could be a widespread process. To asses the preva-
lence of hm5C across different species, a quantitative LC-MS/
MS method was implemented with stable isotope-labelled (SIL)
internal standards, which were spiked into samples and calibra-
tion standards.[17] Its presence and concentrations were deter-
mined by using both the LC and MS/MS selectivity. To apply
this method to the detection and quantification of m5C and
hm5C in RNA, SIL standards for cytidine, m5C and hm5C were
synthesised as depicted in Scheme 2.[18] Thus, 2-13C,15N2-la-
belled uracil was synthesized from a commercial source of [2-
13C,15N2]urea and used in a Vorbrggen coupling with an acyl-
protected ribose donor in the presence of a Lewis acid to yield
2’,3’,5’-tri-O-benzoyl-[2-13C,1,3-15N2]uridine (2 ; Scheme 2A).
Treatment of 2 with tri-(1,2,4-triazol-4-yl)-N-phosphoramidate
furnished an intermediate N4-triazolyl species. Subsequent
aminolysis with concentrated aqueous NH4OH and saponifica-
tion of the benzoyl esters under Zempln conditions yielded
[2-13C,1,3-15N2]cytidine (3). 5-Hydroxymethyl-[2-
13C,1,3-15N2]-
cytidine (4) was obtained from hydroxymethylation of 3 by
adapting published procedures in a microwave-assisted formy-
lation reaction in combination with the use of a cyclic acetal
protecting group to aid purification.[19] 5-[Methyl-D3]-[6D]cyti-
dine (6) was synthesized from [D4]thymine by using the same
sequence of reactions as was used for the synthesis of 3
(Scheme 2B).
With the stable-isotope-labelled internal standards in hand,
we examined the abundance of hm5C in total RNA samples
from model organisms representing the three domains of life
by using a previously described methodology.[20] We chose the
archaeal species Methanocaldococcus jannaschii, the bacterium
Escherichia coli and two eukaryotic model organisms, namely
a plant (Arabidopsis thaliana) and a nematode (Caenorhabditis
elegans). HEK293T cells and mammalian tissues[21] were ana-
lysed to verify previously reported results.[15] To rule out oxida-
tion of m5C to hm5C as a result of downstream RNA process-
ing, we subjected synthetic RNA 122-mers to identical RNA ex-
traction and enzymatic digestion. No oxidation was detected
in the quantitative LC-MS/MS analysis of these control sam-
ples.
We detected hm5C in all samples studied (Figure 1), thus
confirming RNA C5-hydroxymethylation as a common RNA
modification. Notably, hm5C was found in species that do not
exhibit detectable hm5dC in their DNA and lack TET homo-
logues in their genomes, such as C. elegans and A. thaliana.[22]
This suggests that, in such organisms, the formation of hm5C
in RNA must occur through a non-TET mechanism. As noted
by Fu et al. , their observation that TET-null ES cells in which
TET1, TET2, and TET3 are genetically deleted still exhibit signifi-
Scheme 1. In vivo methylation and subsequent oxidation of cytidine as de-
tected by MS analysis of RNA from the brain of mice fed with l-[methyl-
13CD3]methionine. Numbers correspond to the ratio of peak areas of the
depicted labelled nucleosides (in grey) against the respective unlabelled
nucleosides (in brackets). See Figure S6.1 and Table S6.3 for extracted ion
count chromatograms and absolute values obtained thereof, and Table S6.4
for HR-LC-MS/MS data.
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cant hm5C levels in RNA also supports the idea that hm5C in
RNA can form from pathways that do not involve TET en-
zymes.[15] Comparison of m5C oxidation into hm5C across the
different species revealed varying levels (Figure 2). This could
also indicate that RNA hydroxymethylation is the result of dif-
ferent enzymatic transformations. It will ultimately be essential
to map the position of hm5C to specific RNAs in order to un-
derstand its function. As a step towards elucidating hm5C loca-
tion, we explored the abundance of hm5C in RNA classes other
than tRNA and rRNA. Specifically, we isolated mRNA and
lncRNAs from HEK293T cells that contain a polyA tail by RNA
pulldown using polyT magnetic beads. Subsequent analysis of
this fraction by LC-MS/MS allowed us to measure hm5C (Fig-
ure S6.2 in the Supporting Information). In these samples, the
extent of C5-hydroxymethylation in polyA RNA was 40 times
higher than in total RNA (Table S6.5). Currently, the function of
m5C in mRNA and lncRNA is not clearly understood. However,
the presence and levels of hm5C as an oxidative m5C metabo-
lite in polyA RNA suggests that hm5C and m5C might be part
of a dynamic regulatory mechanism. Further studies are
needed to assess the functional roles of m5C and hm5C in RNA.
In summary, we have shown for the first time that 5-hydrox-
ymethylcytosine in RNA is generated by m5C oxidation in vivo
and is pervasive in all three domains of life across a variety of
different species. Our findings suggest the existence of dynam-
ic m5C metabolism in RNA that might have important roles in
RNA function.
Experimental Section
All in vivo experiments were performed under the terms of a UK
Home Office licence. C57BL/6J (JAX mice strain) mice were bred
and housed according to UK Home Office guidelines. Detailed
information on the mouse labelling study, cell culture and subse-
quent RNA extraction (TRI reagent, Sigma) and purification (RNA
clean & concentrator kit, Zymo Research) is given in the Support-
ing Information. Synthetic procedures and full compound charac-
Scheme 2. Synthesis of stable-isotope-labelled cytidine, 5-methylcytidine and 5-hydroxymethylcytidine: a) polyphosphoric acid, 17 h, 95 8C, 37%; b) TMSCl,
1,1,1,3,3,3-hexamethyldisilazane, MeCN, 14 h, 85 8C; c) 1-O-acetyl-2,3,5-tri-O-benzoyl-b-d-ribofuranose, TMSOTf, 1,2-dichloroethene, 4 h, 70 8C, 80%; d) tris(3,5-
dihydro-4H-1,2,4-triazol-4-yl)phosphine oxide, MeCN, 17 h, 25 8C; e) NH4OH (35%), 1,4-dioxane, 2 h, 25 8C, 69%; f) NaOMe, MeOH, 5 h, 25 8C, 97%; g) H2SO4,
acetone, 15 h, 25 8C, 87%; h) paraformaldehyde, KOH (0.5m), microwave irradiation, 75 min, 60 8C, 16%; i) 90% TFA, 1 h, 0 8C, 98%. Asterisks represent a 15N or
13C isotopologue.[18]
Figure 1. Levels of m5C and hm5C across different model organisms given in
amounts relative to the sum of (modified) cytosine residues.[20]
Figure 2. The abundance of hm5C as a fraction of m5C in various organisms.
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terization for all compounds and 1H and 13C NMR spectra of 3, 4
and 6 can also be found in the Supporting Information.
RNA was digested by using a mixture of Benzonase (Sigma), snake
venom phosphodiesterase I (Crotalus adamanteus venom, Sigma)
and antarctic phosphatase (New England Biolabs) in a Tris·HCl
buffer (pH 8) for 12 h. A solution of SIL C, m5C and hm5C used for
LC-MS/MS quantitation was added to samples before the enzymat-
ic digestion.
LC-MS/MS analysis was performed by using an Agilent 1290 Infinity
UHPLC system coupled to an AB Sciex 6500 triple-quadrupole
mass spectrometer. Chromatographic conditions typically consisted
of using a Waters Acquity UPLC HSS T3 column and an H2O/MeCN
(0.1% formic acid) linear gradient.
Acknowledgements
This work was supported by the Cambridge PhD Training Pro-
gramme in Chemical Biology and Molecular Medicine and the
Wellcome Trust (grant number 099232/Z/12/Z). Dr. Donna Bond
is thanked for the provision of A. thaliana total RNA and Drs.
Santiago Uribe-Lewis and Adele Murrell are acknowledged for
the labelled mouse tissue supply.
Keywords: 5-hydroxymethylcytosine · 5-methylcytosine ·
isotope tracing · LC-MS/MS · RNA modifications
[1] M. A. Machnicka, K. Milanowska, O. O. Oglou, E. Purta, M. Kurkowska, A.
Olchowik, W. Januszewski, S. Kalinowski, S. Dunin-Horkawicz, K. M.
Rother, M. Helm, J. M. Bujnicki, H. Grosjean, Nucleic Acids Res. 2013, 41,
D262–D267.
[2] Y. Motorin, F. Lyko, M. Helm, Nucleic Acids Res. 2010, 38, 1415–1430.
[3] J. E. Squires, H. R. Patel, M. Nousch, T. Sibbritt, D. T. Humphreys, B. J.
Parker, C. M. Suter, T. Preiss, Nucleic Acids Res. 2012, 40, 5023–5033.
[4] T. Amort, M. F. Soulire, A. Wille, X.-Y. Jia, H. Fiegl, H. Wçrle, R. Micura, A.
Lusser, RNA Biol. 2013, 10, 1002–1008.
[5] C. Yi, T. Pan, Acc. Chem. Res. 2011, 44, 1380–1388.
[6] G. Jia, Y. Fu, X. Zhao, Q. Dai, G. Zheng, Y. Yang, C. Yi, T. Lindahl, T. Pan,
Y.-G. Yang, C. He, Nat. Chem. Biol. 2011, 7, 885–887.
[7] G. Zheng, J. A. Dahl, Y. Niu, P. Fedorcsak, C.-M. Huang, C. J. Li, C. B.
Vgbø, Y. Shi, W.-L. Wang, S.-H. Song, Z. Lu, R. P. G. Bosmans, Q. Dai, Y.-J.
Hao, X. Yang, W.-M. Zhao, W.-M. Tong, X.-J. Wang, F. Bogdan, K. Furu, Y.
Fu, G. Jia, X. Zhao, J. Liu, H. E. Krokan, A. Klungland, Y.-G. Yang, C. He,
Mol. Cell 2013, 49, 18–29.
[8] X. Wang, Z. Lu, A. Gomez, G. C. Hon, Y. Yue, D. Han, Y. Fu, M. Parisien, Q.
Dai, G. Jia, B. Ren, T. Pan, C. He, Nature 2014, 505, 117–120.
[9] Y. Fu, D. Dominissini, G. Rechavi, C. He, Nat. Rev. Genet. 2014, 15, 293–
306.
[10] S. Hussain, A. A. Sajini, S. Blanco, S. Dietmann, P. Lombard, Y. Sugimoto,
M. Paramor, J. G. Gleeson, D. T. Odom, J. Ule, M. Frye, Cell. Rep. 2013, 4,
255–261.
[11] a) S. Kriaucionis, N. Heintz, Science 2009, 324, 929–930; b) M. Tahiliani,
K. P. Koh, Y. Shen, W. A. Pastor, H. Bandukwala, Y. Brudno, S. Agarwal,
L. M. Iyer, D. R. Liu, L. Aravind, A. Rao, Science 2009, 324, 930–935.
[12] S. Ito, L. Shen, Q. Dai, S. C. Wu, L. B. Collins, J. A. Swenberg, C. He, Y.
Zhang, Science 2011, 333, 1300–1303.
[13] M. Bachman, S. Uribe-Lewis, X. Yang, M. Williams, A. Murrell, S. Balasu-
bramanian, Nat. Chem. 2014, 6, 1049–1055.
[14] I. Rcz, I. Kirly, D. Lsztity, Planta 1978, 142, 263–267.
[15] L. Fu, C. R. Guerrero, N. Zhong, N. J. Amato, Y. Liu, S. Liu, Q. Cai, D. Ji, S.-
G. Jin, L. J. Niedernhofer, G. P. Pfeifer, G.-L. Xu, Y. Wang, J. Am. Chem.
Soc. 2014, 136, 11582–11585.
[16] S. C. Lu, Int. J. Biochem. Cell Biol. 2000, 32, 391–395.
[17] a) E. Ciccimaro, I. A. Blair, Bioanalysis 2010, 2, 311–341; b) J. J. Dalluge,
T. Hashizume, J. A. McCloskey, Nucleic Acids Res. 1996, 24, 3242–3245;
c) T. Brckl, D. Globisch, M. Wagner, M. Mller, T. Carell, Angew. Chem.
Int. Ed. 2009, 48, 7932–7934; Angew. Chem. 2009, 121, 8074–8077.
[18] See the Supporting Information for detailed synthetic procedures and
spectroscopic data.
[19] a) M. Khurshid, A. Khan, M. Qudrat-E-Khuda, J. Chem. Soc. Pak. 1982, 4,
167–168; b) A. A.-H. Abdel-Rahman, E. S. H. El Ashry, Synlett 2002,
2043–2044.
[20] See Tables S6.1 and Table S6.2 for exact values.
[21] See Figure S6.3 for hm5C abundance in mammalian tissues.
[22] S. Liu, T. L. Dunwell, G. P. Pfeifer, J. M. Dunwell, I. Ullah, Y. Wang, PLoS
One 2013, 8, e84620.
Received: January 9, 2015
Published online on February 12, 2015
ChemBioChem 2015, 16, 752 – 755 www.chembiochem.org  2015 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim755
Communications
